Canada · Health Canada Drug Product Database

AMINOSYN II WITH ELECTROLYTES IN DEXTROSE INJECTION WITH CALCIUM

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
47126
DIN
00851574
Form
Solution
Company as listed by source
HOSPIRA HEALTHCARE ULC
Source status
Cancelled Post Market (2012-08-03)
Source last updated
2025-03-22

Source-listed ingredients

  • L-ISOLEUCINE — 280 MG — per 100 ML
  • L-LEUCINE — 425 MG — per 100 ML
  • LYSINE (LYSINE ACETATE) — 446 MG — per 100 ML
  • METHIONINE — 73 MG — per 100 ML
  • L-PHENYLALANINE — 126 MG — per 100 ML
  • L-THREONINE — 170 MG — per 100 ML
  • TRYPTOPHAN — 85 MG — per 100 ML
  • L-VALINE — 212 MG — per 100 ML
  • L-ALANINE — 422 MG — per 100 ML
  • L-ARGININE — 432 MG — per 100 ML
  • L-ASPARTIC ACID — 298 MG — per 100 ML
  • GLUTAMIC ACID — 314 MG — per 100 ML
  • GLYCINE — 212 MG — per 100 ML
  • HISTIDINE — 128 MG — per 100 ML
  • L-PROLINE — 307 MG — per 100 ML
  • SERINE — 225 MG — per 100 ML
  • ACETYL-L-TYROSINE — 115 MG — per 100 ML
  • DEXTROSE — 20 G — per 100 ML
  • SODIUM CHLORIDE — 205 MG — per 100 ML
  • POTASSIUM CHLORIDE — 22 MG — per 100 ML
  • MAGNESIUM CHLORIDE — 51 MG — per 100 ML
  • CALCIUM CHLORIDE — 37 MG — per 100 ML
  • POTASSIUM PHOSPHATE DIBASIC — 261 MG — per 100 ML

These values do not establish equivalence or a dose recommendation.

Packages

  • 1000ml

Source and coverage

Open Health Canada Drug Product Database →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →